Resources from the same session
When can we stop immunotherapy in patients with clinical benefit?
Presenter: Dirk Schadendorf
Session: Special clinical scenarios in management of advanced melanoma
Resources:
Slides
Webcast
What is the current systemic approach in poor prognostic advanced melanomas?
Presenter: Paul Lorigan
Session: Special clinical scenarios in management of advanced melanoma
Resources:
Slides